Matched-Pair Comparison of Radioembolization Plus Best Supportive Care Versus Best Supportive Care Alone for Chemotherapy Refractory Liver-Dominant Colorectal Metastases

被引：0
|
作者：
Ricarda Seidensticker
Timm Denecke
Patrick Kraus
Max Seidensticker
Konrad Mohnike
Jörg Fahlke
Erika Kettner
Bert Hildebrandt
Oliver Dudeck
Maciej Pech
Holger Amthauer
Jens Ricke
机构：
[1] Universitätsklinikum Magdeburg,Klinikum Magdeburg
[2] Klinik für Radiologie & Nuklearmedizin,undefined
[3] Universitätsmedizin Berlin,undefined
[4] Universitätsklinikum Magdeburg,undefined
[5] Klinik für Allgemein-,undefined
[6] Viszeral- und Gefäßchirurgie,undefined
[7] Klinik für Hämatologie/Onkologie,undefined
[8] Universitätsmedizin Berlin,undefined
来源：
CardioVascular and Interventional Radiology | 2012年 / 35卷
关键词：
Radioembolization; Yttrium-90; Liver metastases; Colorectal cancer; Salvage therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1066 / 1073
页数：7
相关论文
共 50 条
  • [41] Oxaliplatin/folinic acid/5-fluorouracil [24h] (OFF) plus best supportive care versus best supportive care alone (BSC) in second-line therapy of gemcitabine-refractory advanced pancreatic cancer (CONKO 003).
    Oettle, H
    Pelzer, U
    Stieler, J
    Hilbig, A
    Roll, L
    Schwaner, I
    Adler, M
    Detken, S
    Dörken, B
    Riess, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 315S - 315S
  • [42] Treatment of locally advanced pancreatic carcinoma in Sweden - A health economic comparison of palliative treatment with best supportive care versus palliative treatment with gemcitabine in combination with best supportive care
    Ragnarson-Tennvall, G
    Wilking, N
    PHARMACOECONOMICS, 1999, 15 (04) : 377 - 384
  • [43] Treatment of locally advanced pancreatic carcinoma in Sweden: A health economic comparison of palliative treatment with best supportive care versus palliative treatment with gemcitabine in combination with best supportive care
    Ragnarson-Tennvall G.
    Wilking N.
    PharmacoEconomics, 1999, 15 (4) : 377 - 384
  • [44] Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial
    Machiels, Jean-Pascal
    Subramanian, Somasundaram
    Ruzsa, Agnes
    Repassy, Gabor
    Lifirenko, Igor
    Flygare, Annika
    Sorensen, Per
    Nielsen, Tina
    Lisby, Steen
    Clement, Paul M. J.
    LANCET ONCOLOGY, 2011, 12 (04): : 333 - 343
  • [45] Secondline Chemotherapy Versus Best Supportive Care in Patient with Malignant Pleural Mesothelioma: A Retrospective Study
    Mutlu, Hasan
    Buyukcelik, Abdullah
    Karaca, Halit
    Aksahin, Arzu
    Berk, Veli
    Aslan, Tuncay
    Erden, Abdulsamet
    Akca, Zeki
    Ozkan, Metin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) : 3887 - 3889
  • [46] Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients
    Caballero-Banos, Miguel
    Benitez-Ribas, Daniel
    Tabera, Jaime
    Varea, Sara
    Vilana, Ramon
    Bianchi, Luis
    Ramon Ayuso, Juan
    Pages, Mario
    Carrera, Gemma
    Cuatrecasas, Miriam
    Martin-Richard, Marta
    Cid, Joan
    Lozano, Miguel
    Castells, Antoni
    Garcia-Albeniz, Xabier
    Maurel, Joan
    Vilella, Ramon
    EUROPEAN JOURNAL OF CANCER, 2016, 64 : 167 - 174
  • [47] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: JAVELIN Bladder 100 subgroup analysis based on duration and cycles of first-line chemotherapy
    Powles, Thomas
    Loriot, Yohann
    Duran, Miguel A. Climent
    Sridhar, Srikala
    Bellmunt, Joaquim
    Petrylak, Daniel P.
    Wang, Jing
    Costa, Nuno
    Laliberte, Robert
    di Pietro, Alessandra
    Grivas, Petros
    Sternberg, Cora N.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 132 - 133
  • [48] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma not progressed with first-line chemotherapy: prespecified subgroup analyses from JAVELIN Bladder 100
    Lumba, Sumit
    Grivas, Petros
    Park, Se Hoon
    Voog, Eric
    Caserta, Claudia
    Valderrama, Begona P.
    Gurney, Howard
    Kalofonos, Haralabos
    Radulovic, Sinisa
    Demey, Wim
    Ullen, Andres
    Loriot, Yohann
    Sridhar, Srikala S.
    Tsuchiya, Norihiko
    Kopyltsov, Evgeny
    Gupta, Shilpa
    Huang, Bo
    Costa, Nuno
    Blake-Haskins, John A.
    di Pietro, Alessandra
    Powles, Thomas
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 42 - 43
  • [49] Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract
    Bellmunt, Joaquim
    Theodore, Christine
    Demkov, Tomasz
    Komyakov, Boris
    Sengelov, Lisa
    Daugaard, Gedske
    Caty, Armelle
    Carles, Joan
    Jagiello-Gruszfeld, Agnieszka
    Karyakin, Oleg
    Delgado, Francois-Michel
    Hurteloup, Patrick
    Morsli, Nassim
    Salhi, Yacine
    Culine, Stephane
    von der Maase, Hans
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) : 4454 - 4461
  • [50] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma not progressed with first-line chemotherapy: Prespecified subgroup analyses from JAVELIN Bladder 100
    Lumba, Sumit
    Grivas, Petros
    Park, Se Hoon
    Voog, Eric
    Caserta, Claudia
    Valderrama, Begona P.
    Gurney, Howard
    Kalofonos, Haralabos
    Radulovic, Sinisa
    Demey, Wim
    Ullen, Anders
    Loriot, Yohann
    Sridhar, Srikala S.
    Tsuchiya, Norihiko
    Kopyltsov, Evgeny
    Gupta, Shilpa
    Huang, Bo
    Costa, Nuno
    Blake-Haskins, John A.
    di Pietro, Alessandra
    Powles, Thomas
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 126 - 126
12345